Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Immunocorp

1998 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of immune system support products. The company offers products like Beta 1,3/1,6 Glucan which is extracted from the cell walls of baker's yeast.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Food Products
Parent Company
Sana Pharma
Primary Office
  • 2340 Mira Mar Avenue
  • Long Beach, CA 90815
  • United States

+1 (800) 000-0000

Immunocorp Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Immunocorp‘s full profile, request access.

Request full access to PitchBook

Immunocorp Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Immunocorp‘s full profile, request access.

Request full access to PitchBook

Immunocorp Executive Team (1)

Name Title Board
Seat
Contact
Info
Mike Gulline Design Director